Enhance and accelerate your early stage research with trusted and comprehensive intelligence from Thomson Reuters.

Start your free trial in just two simple steps.

Get your FREE trial

Enrich your discovery science with market leading, manually curated scientific intelligence. Systems Biology, Preclinical, Biomarkers, Chemistry, Biology, and Pharmacology - and everything in between. Covered from the perspective that matters most – yours.
Customer Feedback
Customer Feedback

Annette Bakker, Chief Scientific Officer from CTF, explains the reasons why she likes to work with Thomson Reuters. Currently using MetaCore™ to identify disease treatment options.

Live & Recorded Training

Attend one of our regularly scheduled webinar training sessions for overviews of features, tools, and content – find the schedule here

Free Pathway Maps

Search or browse through a wide range of proprietary multi-step canonical pathway maps here.

Featured News

The latest news from Life Sciences Research
The future of COPD treatment

The future of COPD treatment

Our research shows greater focus on preventative therapies

Translational Medicine

Translational Medicine

Supplement-Size Doses of Antioxidants Hasten Lung Cancer Progression

Tet Proteins Erase Epigenetic Marks

Tet Proteins Erase Epigenetic Marks

It is (reasonably) common knowledge that DNA is written in a simple four-letter code: ACTG. Too simple, actually.

Blog Highlights

Read our latest blog posts

Russia’s Government Still Pushing for a Stronger Localized Pharma Industry

Early last month, the Kremlin released news of a Russian held forum regarding the Pharma 2020 plan. Over 600 government officials, doctors, regulatory members, and ...

18th Annual IGPA Conference: Global Market Dynamics for Generics & Biosimilars

Around the world economic factors are putting pressure on payers for prescription drugs. This in turn is putting pressure on prices, forcing all parts of ...

Evaluating the “Cost Of Free”: The Importance of Data Integrity for Patent Protection

In today’s increasingly competitive environment, pharmaceutical companies must seek out ways to continuously cut costs, while retaining quality, competitive edge, patent protection, and regulatory compliance ...

Whitepapers & Publications

View our recent whitepapers and publications

Biomarkers: An indispensible addition to the drug development toolkit

In this white paper, Thomson Reuters explores the role of biomarkers as evaluative tools in improving clinical research and the ...


Latest on Twitter

Latest on Linked In